T1	Participants 156 191	glucocorticoid-induced osteoporosis
T2	Participants 330 365	glucocorticoid-induced osteoporosis
T3	Participants 869 877	Patients
T4	Participants 1083 1292	subgrouped by age; gender; menopausal status in women; dose and duration of prednisone during the trial; and baseline serum 25-OH vitamin D, LS BMD T-score, creatinine clearance, and concomitant medication use
T5	Participants 2246 2313	glucocorticoid-induced osteoporosis across a wide range of patients
